These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14722939)

  • 21. [Primary resistance of Mycobacterium tuberculosis].
    Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
    Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
    Vasil'eva IA; Chernousova LN; Zasedatelev AS; Sobolev AIu; Mikhaĭlovich VM
    Probl Tuberk; 2002; (6):21-4. PubMed ID: 12227044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
    Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
    Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179
    [No Abstract]   [Full Text] [Related]  

  • 24. Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis.
    Niemann S; Richter E; Rüsch-Gerdes S; Schlaak M; Greinert U
    Emerg Infect Dis; 2000; 6(5):548-51. PubMed ID: 10998389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona.
    Tudó G; Rey E; Borrell S; Alcaide F; Codina G; Coll P; Martín-Casabona N; Montemayor M; Moure R; Orcau A; Salvadó M; Vicente E; González-Martín J
    J Antimicrob Chemother; 2010 Nov; 65(11):2341-6. PubMed ID: 20802233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detection of primary drug resistance rates of Mycobacterium tuberculosis complex strains isolated between 2002-2003 years and comparison with the data of 1998-2001 period].
    Baylan O; Albay A; Kisa O; Tekbaş OF; Deniz O
    Mikrobiyol Bul; 2005 Apr; 39(2):153-60. PubMed ID: 16128025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Totally drug-resistant tuberculosis in India.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues C
    Clin Infect Dis; 2012 Feb; 54(4):579-81. PubMed ID: 22190562
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Control of drug-sensitive and (multi-)resistant tuberculosis].
    Borgdorff MW
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1525-7. PubMed ID: 12212497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.
    Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S
    Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
    Jaganath D; Schaaf HS; Donald PR
    J Antimicrob Chemother; 2017 Jul; 72(7):1848-1857. PubMed ID: 28333284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
    Afanas'ev MV; Ikriannikova LN; Il'ina EN; Smirnova TG; Larionova EE; Kuz'min AV; Chernousova LN; Kamaev EIu; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    Probl Tuberk Bolezn Legk; 2007; (7):37-42. PubMed ID: 17722291
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
    [No Abstract]   [Full Text] [Related]  

  • 40. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.